Fighting Lupus | GenomeWeb

Fighting Lupus

MIT's Technology Review reports on a new approach to treating lupus that could reverse the autoimmune disease's effects on the immune system. Two companies — ImmuPharma in London and Cephalon in Pennsylvania — are collaborating to develop an experimental drug called Lupuzor, which has just ended Phase II trials with some promising data, the Review's Arlene Weintraub says. Instead of shutting down the immune system the way chemotherapy does, Lupuzor targets T and B cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.